A146V (p.Ala146Val) variant of KRAS (GTPase KRas)

A146V (p.Ala146Val) in KRAS (GTPase KRas) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic/likely pathogenic in the context of Familial pancreatic carcinoma; not provided; KRAS-related disorder. The available variant effect predictions contribute to a CATVariant prioritization score of 0.88 / 1. The record also includes population frequency data, experimental measurements, published literature, and structural context.

A146V (p.Ala146Val) variant details